Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Francois Nader

Affiliations

  • Director at Prevail Therapeutics Inc. (PRVL), 2019-06-25
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2019-05-17
  • Director at Acceleron Pharma Inc (XLRN), 2019-01-29
  • Director at Baxalta Inc (BXLT), 2016-06-07
  • Director at Trevena Inc (TRVN), 2015-05-21
  • President, Ceo And Director at Nps Pharmaceuticals Inc (NPSP), 2015-02-25
  • Director at Noven Pharmaceuticals Inc (NOVN), 2009-08-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NPSP $5.36 30,000 Officer, Director 132,690 2011-11-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NPSP $32.36 43,458 Officer, Director 87,820 2013-09-27 Filing
NPSP $33.60 6,497 Officer, Director 87,820 2013-09-26 Filing
NPSP $33.07 143,503 Officer, Director 94,317 2013-09-26 Filing
NPSP $11.68 148,367 Officer, Director 217,478 2013-04-10 Filing
NPSP $11.27 150,000 Officer, Director 236,860 2013-04-09 Filing